Listen to a podcast, please open Podcast Republic app. Available on Google Play Store and Apple App Store.
| Episode | Date |
|---|---|
|
E98-Inherited Retinal Diseases in 2026 - Dr. Brian Ballios
|
Aug 28, 2026 |
|
E97- Artificial Intelligence in Ophthalmology- Dr. John Kitchens
|
Jun 15, 2026 |
|
E96- Tonabersat for DME- DRCR Protocol AN- Dr. Jennifer Sun
|
May 18, 2026 |
|
E95- Real-World Data of Intraocular Inflammation Associated with Faricimab- Dr. Andrea Montesel
|
Mar 21, 2026 |
|
E94 – Systemic Drugs & Underrecognized Maculopathy - Dr. Seong Joon Ahn
|
Jan 23, 2026 |
|
E93- Slit-Lamp Detection of PVD: A Simpler Way to Diagnose- Dr. Mohsin Ali
|
Dec 25, 2025 |
|
E92-3D Heads-up Display Surgery - Dr. David Chow
|
Nov 29, 2025 |
|
E91- Inherited Retinal Disorders- Progress Promise and Lessons— Dr. Ioannis Dimopoulos
|
Oct 31, 2025 |
|
E90- DRCR Retina Protocol AO- Home OCT for Management of Wet AMD- Dr. Christina Weng
|
Sep 13, 2025 |
|
E89- Artificial Intelligence Image Analysis and Retina Research- Prof. Ursula Schmidt-Erfurth
|
Aug 09, 2025 |
|
E88- SIRE sign, Geographic Atrophy trials and treatments- Prof. Robyn Guymer
|
Jun 28, 2025 |
|
E87- Pachychoroid Disease Spectrum- A deep Dive- Dr. Angie Fong
|
May 16, 2025 |
|
E86-8-Year Cognitive Outcomes of Intravitreal Bevacizumab for ROP- Dr. Wei-Chi Wu
|
Apr 15, 2025 |
|
E85-EyeNovation Webinar- Double Layer Sign- Dr. Usha Chakravarthy
|
Mar 09, 2025 |
|
E84-Long-term Results of PIVOT and Suprachoroidal Viscopexy for RD Repair
|
Jan 12, 2025 |
|
E83-Systemic Methotrexate and Lower Rate of PVR Formation- Dr. Cindy Chen
|
Dec 10, 2024 |
|
E82-Effect of Perfluorocarbon on Distortion after Repair of Retinal Detachment- Prof. Maher Saleh
|
Nov 11, 2024 |
|
E81- Laser Retinopexy in Eyes With High-Risk Lattice Degeneration- Dr. Marc Spirn
|
Oct 07, 2024 |
|
E80-Retinal Vasculitis After Intravitreal Pegcetacoplan- Dr. Andre Witkin from ASRS Research and Safety in Therapeutics (ReST) Committee
|
Aug 05, 2024 |
|
E79- Interaction Between Optometry and The Specialty of Retina- Panel Discussion
|
Jul 27, 2024 |
|
E78- Effect of Scleral Buckle on Outflow Facility, Intraocular Pressure, and Ocular Biomechanics- Dr. Arthur Sit
|
Jun 17, 2024 |
|
E77-Indivisual and Systemic Risk Factors for Diabetic Vitrectomy- Dr. Paul Micevych
|
May 14, 2024 |
|
E76-EDI landscape in Canadian Ophthalmology Residency Programs
|
Mar 31, 2024 |
|
E75-PED Height and Variabiility and Outcomes of wet AMD Treatment- Dr. David Sarraf
|
Feb 28, 2024 |
|
E74- Full-Thickness Macular Holes in Macular Telangiectasia Type 2- Dr. Jong Park
|
Dec 30, 2023 |
|
E73- RD associated with Retinal Dialysis- Dr. Rohowetz
|
Dec 02, 2023 |
|
E72-The MERIT Trial
|
Oct 28, 2023 |
|
E71- GA progression on Asian vs non-Asian Eyes- Prof Gemmy Cheung
|
Sep 16, 2023 |
|
E70-Archway 3 Port Delivery System for wAMD- Dr. Carl Regillo
|
Jul 26, 2023 |
|
E69- DRCR Protocol AC Cost Analysis- Dr. William Smiddy
|
Jun 19, 2023 |
|
E68-Retinectomy without Lensectomy for RD with PVR- Dr. Jason Hsu
|
May 09, 2023 |
|
E67-DAVIO Trial- extended release EYP-1901 for wet AMD- Dr. Jay Duker
|
Apr 10, 2023 |
|
E66-DIAMONDS Study- Micropulse Laser vs Standard Laser for DME- Prof. Noemi Lois
|
Mar 07, 2023 |
|
E65-Incidence of delayed retinal tears after symptomatic PVD- Dr. Jing Chen
|
Dec 01, 2022 |
|
E64-DRCR Protocol AC-Aflibercept Monotherapy or Bevacizumab First for DME- Dr. Chirag Jhaveri
|
Oct 30, 2022 |
|
E63- Vitrectomy vs Vitrectomy plus Scleral Buckle for Repair of Retina Detachments Due to Giant Retina Tears- Dr. Fernando Arevalo
|
Sep 15, 2022 |
|
E62-CRVO and HRVO Associated with COVID-19 Infection in Young Patients-Dr. Avni Finn
|
Jun 27, 2022 |
|
E61- Air vs SF6 for small-medium macular holes- Dr. Birger Lindtjørn
|
May 23, 2022 |
|
E60-Reticular Pseudodrusen and Progression to Advanced AMD- Prof. Robyn Guymer
|
May 02, 2022 |
|
E59-Novel RCBTB1 variants and late-onset retinal dystrophy- Dr. Brian Ballios
|
Mar 21, 2022 |
|
E58-Drainage Techniques for Retina Detachment Repair-Dr. Vinod Kumar
|
Feb 28, 2022 |
|
E57-PAMM and the Ischemic Cascade- Dr. David Sarraf
|
Jan 17, 2022 |
|
E56-C5 Inhibitor Avacincaptad Pegol for Geographic Atrophy- Dr. Kourous Rezaei
|
Dec 24, 2021 |
|
E55-Minimized Eye Movement and Laser for RD Repair- Dr. Gregg Kokame
|
Nov 16, 2021 |
|
E54-Macular Hydrodissection, Scleral Needling and Preop Gas- Dr. Efrem Mandelcorn
|
Nov 02, 2021 |
|
E53-Optogenetic Vision Recovery for Retinitis Pigmentosa-Drs. Sahel and Roska
|
Oct 05, 2021 |
|
E52-Complications of Acute PVD- Dr. Michael Seider
|
Sep 20, 2021 |
|
E51-COVID-19 and anti-septics, Ocular Tissue Detection, & Ontario Surgical Backlog-Dr. Tina Felfeli
|
Jul 19, 2021 |
|
E50-Vision Recovery Velocity, Momentum and Acceleration-Dr. David Almeida
|
Jun 14, 2021 |
|
E49-SCREENROP Study. Refining ROP Screening Guidelines- Dr. Kourosh Sabri
|
May 28, 2021 |
|
E48-DRCR Protocol W 2-year Results: Prophylactic anti-VEGF for Mod-Severe NPDR
|
Apr 20, 2021 |
|
E47-Nondamaging Retinal Laser for Mac Tel Type II- Dr. Daniel Lavinsky
|
Mar 13, 2021 |
|
E46- DRCR Protocol AB. Anti-VEGF vs PPV for PDR w Vit Heme-Dr. Andrew Antoszyk
|
Feb 13, 2021 |
|
E45- Stress in Medicine- Book Club with Dr. Nina Ahuja
|
Jan 27, 2021 |
|
E44- Representation of Women in Vitreoretinal Meetings- Dr. Jay Sridhar
|
Dec 24, 2020 |
|
E43- Retinal Findings in Hospitalized COVID-19 Patients- Dr. Leonardo Pereira
|
Dec 03, 2020 |
|
E42-Peripheral Exudative Hemorrhagic Chorioretinopathy- Dr. Federico Zicarelli
|
Nov 02, 2020 |
|
E41- Treatment of Secondary Macular Holes with Topical Therapy- Dr. John Niffenegger
|
Oct 05, 2020 |
|
E40-Retinal Vasculitis and Intraocular Inflammation with Brolucizumab - Dr. Caroline Baumal
|
Sep 07, 2020 |
|
E39- Slit Lamp Shields and Face Masks for COVID-19. Dr. Victor Koh
|
Aug 22, 2020 |
|
E38-Retinal Biomarkers of Alzheimer's Disease- Drs. Cecilia Lee and Rajendra Apte
|
Jul 14, 2020 |
|
E37- Retinal Detachment Rates after Intravitreal Anti-VEGF Injections- Dr. Omesh Gupta
|
Jun 08, 2020 |
|
E36- COVID-19 and Preparedness among Ophthalmologists- International Panel Discussion. Drs. Dan Ting, Olivia Li and Steven Yeh
|
Apr 20, 2020 |
|
E35- COVID-19 Mortality and Public Mask Usage- Dr. Christopher Leffler
|
Apr 06, 2020 |
|
E34- Progression of glaucoma after anti-VEGF injections in susceptible eyes- Dr. Eugene Shildkrot
|
Mar 29, 2020 |
|
LEAVO Trial - Comparison of Anti-VEGF drugs for Macular Edema Secondary to CRVO- Dr. Philip Hykin.
|
Feb 27, 2020 |
|
E32-Change in Management after Vitreous Culture in Endophthalmitis after Intravitreal Injections-Dr. James Vander
|
Jan 28, 2020 |
|
E31- FLUID Study - Dr. Robyn Guymer
|
Dec 10, 2019 |
|
E30-Clinical Predictors of Low-Risk Histopathology for Retinoblastoma- Dr. Sameh Soliman
|
Oct 29, 2019 |
|
E29-Anti-VEGF Levels in Breast Milk after Intravitreal Injections-Drs. Muni and Juncal
|
Sep 14, 2019 |
|
E28-Brolucizumab for wet AMD (HAWK and HARRIER)- Dr. Pravin Dugel
|
Sep 02, 2019 |
|
E27-DRCR Protocol V Results- Anti-VEGF vs Focal Laser vs Observation for DME in Eyes with Very Good Vision- Dr. Jennifer Sun
|
Jul 22, 2019 |
|
E26-Autologous Retinal Transplant for Refractory Macular Holes-Dr. Tamer Mahmoud
|
Jun 03, 2019 |
|
E25-RIVAL Study: Ranibizumab vs Aflibercept in T&E for wet AMD- Dr. Mark Gillies
|
Apr 22, 2019 |
|
E24-Acute Retinal Angiographic Changes with Intravitreal Injections-Dr. Richard Rosen
|
Mar 31, 2019 |
|
E23- CANTREAT Study. Ranibizumab Monthly vs Treat-and-Extend for wAMD - Dr. Peter Kertes
|
Feb 22, 2019 |
|
E22-Stroke Risk in Patients with CRAO-Dr. Matthew Schrag
|
Jan 21, 2019 |
|
E21-Eyes with PDR that were Lost to Followup after PRP or Anti-VEGF Treatment- Dr. Jason Hsu
|
Dec 17, 2018 |
|
E20-PIVOT Study: Pneumatic Retinopexy vs PPV for RD Repair
|
Nov 26, 2018 |
|
E19-LEAD Trial for Use of Nanopulse Laser for Dry AMD-Prof. Robyn Guymer
|
Nov 12, 2018 |
|
E18-Red Blood Cell Distribution and Vision Potential in RVO-Dr. Ahmet Ozkok
|
Oct 16, 2018 |
|
E17- 5-year Results of DRCR.net Protocol S: PRP laser vs ranibizumab for PDR- Dr. Jennifer Sun
|
Sep 11, 2018 |
|
E16- PLACE Trial: Half-Dose PDT vs Micropulse Laser for Central Serous Chorioretinopathy- Dr. Camiel Boon
|
Jul 17, 2018 |
|
E15-Serum VEGF Levels in the IVAN Trial- Dr. Usha Chakravarthy
|
Jun 11, 2018 |
|
E14-Plasma VEGF Levels after anti-VEGF Injections (DRCR protocol T)- Dr. Charles Wykoff
|
May 30, 2018 |
|
E13-Long-term Treatment of Wet AMD by 50+ anti-VEGF Injections-Dr. Sean Adrean
|
May 14, 2018 |
|
E12-RPE Stem Cells for Dry AMD-Dr. Mark Humayun
|
Apr 23, 2018 |
|
E11- Endophthalmitis after Intravitreal Anti-VEGF Injections- Dr. David Almeida
|
Apr 09, 2018 |
|
E10-Cytokines Levels and Response to Ranibizumab in DME-Dr. Rajeev Muni
|
Mar 28, 2018 |
|
E9-Rate of Macular Atrophy in HARBOR Study- Dr. SriniVas Sadda
|
Mar 12, 2018 |
|
E8- DAVE Trial: Targeted Retinal Photocoagulation for DME- Dr. David Brown
|
Feb 26, 2018 |
|
E7-Long Term Outcomes of 27-G Vitrectomy- Dr. Ali Khan
|
Feb 13, 2018 |
|
E6- YAG Vitreolysis for Symptomatic Floaters- Dr. Chirag Shah
|
Jan 29, 2018 |
|
E5-Adding Dexamethasone Implant to Ranibizumab for Persistent DME- Dr. Raj Maturi
|
Dec 24, 2017 |
|
E4- 3-year Results of the TREX-AMD Trial- Dr. Charles Wykoff
|
Dec 08, 2017 |
|
E3: 5-year Results of Argus II Retina Prosthesis-Dr. Rob Devenyi
|
Nov 26, 2017 |
|
Autologous Induced Stem-Cell–Derived Retinal Cells for Macular Degeneration
|
Nov 10, 2017 |
|
Review of the Clarity Study
|
Oct 23, 2017 |